NKTX

Nkarta, Inc.

Biotechnology · Biotechnology

$228.09 sample

-0.17 (-0.07%) 1D

Market cap

$316.6B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-16

Alerts

8

Price$228.09 +13.32% 3M daily closessample

232.07201.28

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 24INSInsider buy: Director
Sep 16SEC10-Q filed
Sep 10SEC8-K filed: material event
Sep 03INSInsider sell: Chief Financial Officer
Aug 27INSInsider buy: Chief Executive Officer
Aug 21SEC8-K filed: material event
Aug 14INSInsider sell: EVP, Operations
Aug 05INSInsider sell: General Counsel

Sign up to see the real NKTX record →

Company facts

SEC EDGAR registration

Name: Nkarta, Inc.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +14sample, -100 to +100
Reporting currency: USD

Who is positioning in NKTX

sample

Insiders: 33 insider transactions over 90 days, net selling, $828.3M
Congress: 4 members traded over 90 days
Institutions · 13F: 44 funds hold $7.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$17.6B +23.6% y/y

Q4 2024Q3 2026

Inventory$10.1B +8.7% y/y

Q4 2024Q3 2026

Accounts receivable$7.6B +7.7% y/y

Q4 2024Q3 2026

Total debt$19.9B +4.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $314.1B -3.4% 3M
Sample peer B: $152.5B +6.6% 3M
Sample peer C: $46.9B -12.7% 3M
Sample peer D: $294.6B +3.3% 3M
Sample peer E: $63.3B -4.4% 3M